Table 4.
Meta-Analysis Populations | Gene | MA | rs # | OR | SE | Q | I | P |
---|---|---|---|---|---|---|---|---|
RFTS EA and BioVU | Nearby SLK | T | rs7913069* | 1.11 | 0.25 | 0.33 | 0 | 0.682 |
BET1L | T | rs2280543* | 0.67 | 0.15 | 0.70 | 0 | 6.9×10-3 | |
TNRC6B | G | rs12484776* | 1.21 | 0.07 | 0.24 | 28.37 | 8.7×10-3 | |
RFTS EA, BIOVU EA, and Prior Japanese GWAS † | Nearby SLK | T | rs7913069* | 1.58 | 0.08 | 0.21 | 36.01 | 7.45×10-8 |
BET1L | T | rs2280543* | 0.66 | 0.07 | 0.92 | 0 | 3.89×10-9 | |
TNRC6B | G | rs12484776* | 1.26 | 0.04 | 0.38 | 0 | 1.33×10-8 |
OR = odds ratio, SE =standard error, Q = p value for the Cochrane's Q statistic, I = I2 heterogeneity index (0-100)
Index SNP from previous GWAS. (30)
Highlighted results indicate p ≤ 0.05